Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 3
2002 1
2006 1
2007 1
2008 2
2010 2
2013 1
2014 7
2015 2
2016 2
2017 4
2018 6
2019 2
2020 4
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Results by year
Filters applied: . Clear all
Page 1
Blood pressure in early autosomal dominant polycystic kidney disease.
Schrier RW, Abebe KZ, Perrone RD, Torres VE, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, Hogan MC, Miskulin DC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, Bae KT, Moore CG, Chapman AB; HALT-PKD Trial Investigators. Schrier RW, et al. Among authors: brosnahan g. N Engl J Med. 2014 Dec 11;371(24):2255-66. doi: 10.1056/NEJMoa1402685. Epub 2014 Nov 15. N Engl J Med. 2014. PMID: 25399733 Free PMC article. Clinical Trial.
Expanded Imaging Classification of Autosomal Dominant Polycystic Kidney Disease.
Bae KT, Shi T, Tao C, Yu ASL, Torres VE, Perrone RD, Chapman AB, Brosnahan G, Steinman TI, Braun WE, Srivastava A, Irazabal MV, Abebe KZ, Harris PC, Landsittel DP; HALT PKD Consortium. Bae KT, et al. Among authors: brosnahan g. J Am Soc Nephrol. 2020 Jul;31(7):1640-1651. doi: 10.1681/ASN.2019101121. Epub 2020 Jun 2. J Am Soc Nephrol. 2020. PMID: 32487558
The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD.
Lavu S, Vaughan LE, Senum SR, Kline TL, Chapman AB, Perrone RD, Mrug M, Braun WE, Steinman TI, Rahbari-Oskoui FF, Brosnahan GM, Bae KT, Landsittel D, Chebib FT, Yu AS, Torres VE; HALT PKD and CRISP Study Investigators, Harris PC. Lavu S, et al. Among authors: brosnahan gm. JCI Insight. 2020 Aug 6;5(15):e138724. doi: 10.1172/jci.insight.138724. JCI Insight. 2020. PMID: 32634120 Free PMC article.
Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients.
Hanudel MR, Salusky IB, Pereira RC, Wang W, You Z, Nowak KL, Brosnahan GM, Torres VE, Chapman AB, Perrone RD, Steinman TI, Bae KT, Gitomer BY, Chonchol MB. Hanudel MR, et al. Among authors: brosnahan gm. Kidney Int Rep. 2019 Aug 24;4(12):1742-1748. doi: 10.1016/j.ekir.2019.08.010. eCollection 2019 Dec. Kidney Int Rep. 2019. PMID: 31844811 Free PMC article. No abstract available.
Predictors of autosomal dominant polycystic kidney disease progression.
Schrier RW, Brosnahan G, Cadnapaphornchai MA, Chonchol M, Friend K, Gitomer B, Rossetti S. Schrier RW, et al. Among authors: brosnahan g. J Am Soc Nephrol. 2014 Nov;25(11):2399-418. doi: 10.1681/ASN.2013111184. Epub 2014 Jun 12. J Am Soc Nephrol. 2014. PMID: 24925719 Free PMC article. Review.
Closeout of the HALT-PKD trials.
Moore CG, Spillane S, Simon G, Maxwell B, Rahbari-Oskoui FF, Braun WE, Chapman AB, Schrier RW, Torres VE, Perrone RD, Steinman TI, Brosnahan G, Czarnecki PG, Harris PC, Miskulin DC, Flessner MF, Bae KT, Abebe KZ, Hogan MC. Moore CG, et al. Among authors: brosnahan g. Contemp Clin Trials. 2015 Sep;44:48-55. doi: 10.1016/j.cct.2015.07.017. Epub 2015 Jul 29. Contemp Clin Trials. 2015. PMID: 26231556 Free PMC article.
34 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page